IceCure Medical Ltd
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -1.46 | $907,000 | -$4M |
| 2026 Q1 | -1.74 | $911,000 | -$4M |
| 2025 Q4 | -1.75 | $1M | -$5M |
| 2025 Q3 | -1.77 | $850,000 | -$3M |
| 2025 Q2 | -1.72 | $525,000 | -$3M |
| 2025 Q1 | -1.87 | $725,000 | -$4M |
| 2024 Q4 |
| -2.42 |
| $875,000 |
| -$4M |
| 2024 Q3 | -2.38 | $662,000 | -$3M |